Delivery Order SPE2DB22D2005-SPE2DB25FJKL6

Award Date 3/28/25
Potential Completion Date 4/18/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $2,042.76, is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which enables the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,618.40, is for the delivery of VEKLURY 100 MG vials, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $27,213.60 firm fixed-price contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,618.40, is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract has a period of performance through September 19, 2024 and uses a Firm Fixed Price pricing type. It was awarded on August 28, 2024 and was not set aside for any specific business type....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the major pharmaceutical distributor Amerisourcebergen Drug Corporation. The contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product, with a ceiling value of $6,809.20 and an ultimate completion date of October 2, 2024. Amerisourcebergen, through its Corporate Office division, will deliver these medical supplies to support military treatment facilities...
This is a $4,085.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY 100 MG VIALS. The contract has a completion date of September 5, 2024 and was awarded on August 14, 2024. This order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This federal contract award, awarded by the Defense Logistics Agency (DLA), is a delivery order to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of VEKLURY 100 MG VIALS, a pharmaceutical product, with a ceiling value of $13,618.40 and a completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (remdesivir) 100 mg vials. The contract, valued at $15,848.80, is a firm fixed-price delivery order that runs through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.20 firm fixed price delivery order is for the supply of VEKLURY 100 MG VIALS, which are likely antiviral medications. The contract has an ultimate completion date of March 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of VEKLURY 100 MG Vials, a pharmaceutical product, with a firm fixed price of $3,404.60 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJKL6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of VEKLURY 100 MG VIALS, with a ceiling value of $3,962.20 and an ultimate completion date of April 18, 2025.

The contract is an Indefinite Delivery Contract (IDC) that serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, valued at $999,999,999 and running through November 2026, enables efficient government procurement of essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 6/27/25, 12:09 PM